AEGERION PHARMACEUTICALS LIMITED

08114919
Active London

Wholesale of pharmaceutical goods

0 employees website.com
Wholesale of pharmaceutical goods
A

AEGERION PHARMACEUTICALS LIMITED

08114919

Wholesale of pharmaceutical goods

Founded 21 Jun 2012 Active London, United Kingdom 0 employees website.com
Wholesale of pharmaceutical goods
Accounts Submitted 29 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 2 Jul 2025 Next due 5 Jul 2026 17 days remaining
Net assets £44M £3M 2024 year on year
Total assets £46M £478K 2024 year on year
Total Liabilities £2M £3M 2024 year on year
Charges 3
3 satisfied

Contact & Details

Contact

Registered Address

C/O Corporation Service Company (Uk) Limited 5 Churchill Place 10th Floor London E14 5HU United Kingdom

Website

www.example.com

Full company profile for AEGERION PHARMACEUTICALS LIMITED (08114919), an active company based in London, United Kingdom. Incorporated 21 Jun 2012. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

£8.36M

Increased by £7.24M (+647%)

Net Assets

£44.40M

Increased by £2.58M (+6%)

Total Liabilities

£1.76M

Decreased by £3.06M (-63%)

Turnover

£2.29M

Increased by £320.45k (+16%)

Employees

N/A

Debt Ratio

4%

Decreased by 6 (-60%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 2 Shares £56.67m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Dec 20182£56.67m£28.34m

Officers

Officers

1 active 2 resigned
Status
Matthew Hammond WiggettsDirectorBritishEngland5426 May 2023Active

Shareholders

Shareholders (1)

Aegerion Pharmaceuticals, Ltd
100.0%
3

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Active
Notified 24 Sept 2019
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Novelion Therapeutics Inc.

Ceased 24 Sept 2019

Ceased

Aegerion Pharmaceuticals, Inc.

Ceased 29 Nov 2016

Ceased

Group Structure

Group Structure

AMRYT PHARMA LIMITED united kingdom
AEGERION PHARMACEUTICALS LIMITED Current Company

Charges

Charges

3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
16 Sept 2025AddressChange Registered Office Address Company With Date Old Address New Address
2 Jul 2025Confirmation StatementConfirmation statement made on 21 Jun 2025 with no updates
9 Oct 2024OfficersAppointment of Mr Gerard Feely as director on 26 Sept 2024
3 Oct 2024OfficersTermination of Ailish Hogan as director on 26 Sept 2024
29 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

16 Sept 2025 Address

Change Registered Office Address Company With Date Old Address New Address

2 Jul 2025 Confirmation Statement

Confirmation statement made on 21 Jun 2025 with no updates

9 Oct 2024 Officers

Appointment of Mr Gerard Feely as director on 26 Sept 2024

3 Oct 2024 Officers

Termination of Ailish Hogan as director on 26 Sept 2024

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

8 months ago on 29 Sept 2025

Change Registered Office Address Company With Date Old Address New Address

9 months ago on 16 Sept 2025

Confirmation statement made on 21 Jun 2025 with no updates

11 months ago on 2 Jul 2025

Appointment of Mr Gerard Feely as director on 26 Sept 2024

1 years ago on 9 Oct 2024

Termination of Ailish Hogan as director on 26 Sept 2024

1 years ago on 3 Oct 2024